ISPOR Task Forces are created to advance the field of health care outcomes research and the use of this research in health care decisions. A Task Force is approved by the ISPOR Board of Directors to achieve a defined goal such as the development of a "good research practice" document or similar document. A Task Force is composed of a Leadership Group, who develop the document and a Reviewer Group, who provide feedback and comments to the document. The Leadership Group is selected by the Task Force Chair(s). The Reviewer Group is composed of any ISPOR member who is interested in the goal of the Task Force. When the goal of a Task Force is achieved, the Task Force is dissolved.

New!  Prospective Observational Clinical Studies Good Research Practices Task Force Conjoint Analysis in Health Task Force Health Economic Publication Guidelines Task Force Indirect Treatment Comparisons Task Force Modeling Good Research Practices Task Force PRO: Assessment in Children and Adolescents Task Force PRO: Establishing & Reporting Evidence of the Content Validity of PRO Instruments Task Force Good Research Practices Developed by ISPOR Task Forces ISPOR GOOD OUTCOMES RESEARCH PRACTICES INDEX Pharmacoeconomics: Identifying the Issues Code of Ethics ISPOR Health Science Initiatives Digest of Research Presentations (ISPOR meetings) COMPARATIVE EFFECTIVENESS RESEARCH METHODS Comparative Effectiveness Research: Defining, Reporting and Interpreting Non-randomized Studies of Treatment Effects Using Secondary Databases Comparative Effectiveness Research: Approaches to Mitigate Bias And Confounding in The Design of Non-randomized Studies of Treatment Effects Using Secondary Databases Comparative Effectiveness Research: Analytic Methods to Improve Causal Inference From Non-randomized Studies of Treatment Effects Using Secondary Databases Indirect Treatment Comparisons Good Research Practices (in development) Prospective Observational Clinical Studies Good Research Practices (in development) ECONOMIC OUTCOMES METHODS Principles of Good Practice for Budget Impact Analysis Cost Effectiveness Analysis with Clinical Trials Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective Measuring Drug Costs in Cost-Effectiveness Analyses: A Managed Care Perspective Measuring Drug Costs in Cost-Effectiveness Analyses: Medicare, Medicaid and Other US Government Payers Perspectives Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective Quality Improvement of Cost Effectiveness Research Transferability of Economic Evaluations Across Jurisdictions MODELING METHODS Modeling Studies PATIENT REPORTED OUTCOMES METHODS Quality of Life Methods ISPOR Patient Reported Outcomes /Quality of Life Initiatives PRO / QoL Regulatory Issues PRO: Incorporating the Patient's Perspective into Drug Development and Communication ePRO: Changing Mode of Administration of PRO Instruments From Paper to Electronic PRO: Assessment of Patient Reported Outcomes in Children and Adolescents (in development) PRO: Translation & Cultural Adaptation Process PRO: Translation & Linguistic Validation of PRO Instruments PRO: Evaluating & Documenting Content Validity for the Use of Existing PRO Instruments & Their Modification PRO: Establishing and Reporting Evidence of the Content Validity of PRO Instruments (in development) PREFERENCE-BASED METHODS Conjoint Analysis in Health Good Research Practices (in development) Moving the QALY forward - Consensus development POPULATION METHODS Summary Measurement of Population Health (in development) ISPOR Population Health Initiatives CLINICAL OUTCOMES (USING REAL WORLD DATA) METHODS Database Methods Checklist for Retrospective Database Studies Medication Compliance and Persistence Methods Medication Compliance and Persistence: Terminology and Definitions Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations Medication Compliance and Persistence Issues (in development) Checklist for Prospective Medication Compliance and Persistence Studies (in development) Disease-specific Systematic Reviews of Medication Compliance and Persistence Studies (in development) Medication Compliance and Persistence in Breast Cancer Treatment (in development) Medication Compliance and Persistence in the Treatment of Chronic Diseases (in development) Medication and Persistence in Rheumatoid Arthritis(in development) Disease and Health Management Data & Methods Reliability and Validity of Data Sources for Health and Disease Management (book in development) Patient Registry Methods Taxonomy of Patient Registries: Classification, Characteristics & Terms (book in development) Cost Effectiveness Analysis of Patient Registry Data (in development) Analysis of Effectiveness in Patient Registry Data (in development) Personalized Medicine Issues and Challenges in the Development and Reimbursement of Personalized Medicine (in development) Risk-Benefit Methods Metrics & Methodologies to Quantify Risks & Benefits (in development)